IPO Timeline
Broker Results (T-2)
2021-06-30
Some brokers release in afternoon
Grey Market (T-1)
2021-07-02
Afternoon
HKEX Allotment (T-1)
2021-07-02
Evening
Registrar Allotment (T-1)
2021-07-02
Evening
Listing Day (T)
2021-07-05
First day of trading
Company Overview
| Stock Name | 歸創通橋醫療科技股份有限公司 - B - H股 |
|---|---|
| Stock Code | 02190 |
| Company Full Name | 歸創通橋醫療科技股份有限公司 - B - H股 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事研發、制造及銷售神經及外周血管介入醫療器械。 |
| Listing Date | 2021-07-05 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市余杭區倉前街道數云路270號歸創通橋產業園 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.zyloxtb.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 42.70 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 43.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,281,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 60.0 |
|---|---|
| First Day Open | HK$ 55.0 |
| First Day Change | 40.52% |
| First Day Volume | 58971000.0 |
| First Day Turnover | 3342110000.0 |
Use of Proceeds
| Use of Proceeds | 1、約37.0%，或888.1百萬港元，將被分配予我們的核心產品; 2、約11.0%，或262.2百萬港元，將被分配予我們其他5款主要產品的持續研發、生產及商業化; 3、約40.0%，或959.5百萬港元，將被分配予我們其他38款產品及在研管線，以開發我們的產品組合，進而提供全線解決方案; 4、約3.0%，或71.9百萬港元，將分配予進一步升級研發設施，包括位于杭州及珠海的軟件及硬件基礎設施，以及在珠海計劃進行的辦公室擴建與升級； 5、約4.0%，或95.9百萬港元，將分配予潛在戰略收購、投資、授權引進或合作; 6、約5.0%，或119.9百萬港元，將用于我們的營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
中信证券（香港）有限公司 CE AAK249
Overall Coordinators (6)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
兴证国际融资有限公司 CE BAK956
安信国际证券(香港)有限公司
工银国际证券有限公司 CE ARO299
招银国际融资有限公司 CE AVM940
Joint Bookrunners (6)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
兴证国际融资有限公司 CE BAK956
安信国际证券(香港)有限公司
工银国际证券有限公司 CE ARO299
招银国际融资有限公司 CE AVM940
Joint Lead Managers (6)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
兴证国际融资有限公司 CE BAK956
安信国际证券(香港)有限公司
工银国际证券有限公司 CE ARO299
招银国际融资有限公司 CE AVM940
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | AIHC Master Fund | 124,192,950 HKD | — | 4.85% | — | 6 months | 2022-01-05 |
| 2 | Athos Asia Event Driven Master Fund | 31,042,900 HKD | — | 1.21% | — | 6 months | 2022-01-05 |
| 3 | Boyu Capital Opportunities Master Fund | 124,192,950 HKD | — | 4.85% | — | 6 months | 2022-01-05 |
| 4 | Cormorant Asset Management, LP | 62,085,800 HKD | — | 2.42% | — | 6 months | 2022-01-05 |
| 5 | Fidelity International | 155,235,850 HKD | — | 6.06% | — | 6 months | 2022-01-05 |
| 6 | Hillhouse Funds | 232,843,100 HKD | — | 9.09% | — | 6 months | 2022-01-05 |
| 7 | Hudson Bay Master Fund LTD | 77,607,250 HKD | — | 3.03% | — | 6 months | 2022-01-05 |
| 8 | Lake Bleu Prime Healthcare Master Fund Limited | 155,235,850 HKD | — | 6.06% | — | 6 months | 2022-01-05 |
| 9 | Octagon Investments Master Fund LP | 54,314,400 HKD | — | 2.12% | — | 6 months | 2022-01-05 |
| 10 | Sage Partners Master Fund | 15,521,450 HKD | — | 0.61% | — | 6 months | 2022-01-05 |
| 11 | Snow Lake China Master Fund, Ltd. | 77,607,250 HKD | — | 3.03% | — | 6 months | 2022-01-05 |
| 12 | 常春藤资产管理(香港)有限公司 | 15,521,450 HKD | — | 0.61% | — | 6 months | 2022-01-05 |
Directors & Management
| Chairman | 趙中 |
|---|---|
| Company Secretary | 袁泉衛;關秀妍 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 趙中(12.47%) |
|---|
IPO Timeline
